BlackRock, Inc. Increases Stake in BIO-RAD LABORATORIES, INC.

BlackRock, Inc. has filed a Schedule 13G/A amendment with the SEC, disclosing an increased ownership in BIO-RAD LABORATORIES, INC. As of September 30, 2025, BlackRock beneficially owns 1,618,123 shares of Class A Stock, representing a 7.4% ownership stake. This marks an increase of 458,877 shares, or 39.58%, from their previous holdings. The filing indicates that BlackRock holds sole voting power over 1,561,852 shares and sole dispositive power over all 1,618,123 shares. The filing also certifies that the shares were acquired in the ordinary course of business and not for the purpose of influencing control of the issuer. The amendment includes exhibits such as a Power of Attorney and details on subsidiary identification.